Clinical Trial Update: Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

This document reports on a Phase 1 clinical trial evaluating the combination of irinotecan and gemcitabine in patients with unresectable or metastatic solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Northwestern University | Conditions: Bladder Cancer, Breast Cancer | Phase 1 | Status: COMPLETED